The pharmaceutical world is observing a significant shift in blood sugar therapy with the emergence of GLP-1 patches. These patches offer a possibly more convenient alternative to subcutaneous administrations of GLP-1 medications, reducing the requirement of daily needle pricks. The approach releases the compound directly through the surface, poten